INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 195 filers reported holding INSMED INC in Q2 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,315,834 | +22.2% | 289,736 | +1.8% | 0.02% | +16.7% |
| Q2 2023 | $5,985,580 | +35.3% | 284,621 | +9.7% | 0.02% | +28.6% |
| Q1 2023 | $4,424,884 | -14.7% | 259,524 | -0.1% | 0.01% | -17.6% |
| Q4 2022 | $5,189,026 | -9.9% | 259,711 | -1.4% | 0.02% | -19.0% |
| Q3 2022 | $5,759,000 | +14.2% | 263,306 | +4.8% | 0.02% | +16.7% |
| Q2 2022 | $5,043,000 | -14.7% | 251,249 | -0.2% | 0.02% | +5.9% |
| Q1 2022 | $5,914,000 | -10.4% | 251,642 | +3.9% | 0.02% | +13.3% |
| Q4 2021 | $6,597,000 | +6.1% | 242,175 | +7.2% | 0.02% | +7.1% |
| Q3 2021 | $6,219,000 | +37.0% | 225,815 | +41.6% | 0.01% | +16.7% |
| Q2 2021 | $4,539,000 | -13.0% | 159,499 | +4.1% | 0.01% | -14.3% |
| Q1 2021 | $5,216,000 | +0.4% | 153,149 | -1.9% | 0.01% | 0.0% |
| Q4 2020 | $5,196,000 | +3.9% | 156,079 | +0.3% | 0.01% | -22.2% |
| Q3 2020 | $5,000,000 | +24.1% | 155,580 | +6.4% | 0.02% | +20.0% |
| Q2 2020 | $4,028,000 | +148.6% | 146,271 | +44.7% | 0.02% | +66.7% |
| Q1 2020 | $1,620,000 | – | 101,060 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |